STOCK TITAN

Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Zynex, Inc. (NASDAQ: ZYXI) has been ranked on Deloitte's Technology Fast 500 list for the fifth year in a row and ninth time overall. Revenues grew 248% between 2019 and 2022, with 2022 revenue reaching $158.2 million. The company estimates 2023 revenue between $189.5 and $194.5 million. This recognition reinforces Zynex's position as a leading provider of non-invasive medical devices for pain management, rehabilitation, and patient monitoring.
Positive
  • Zynex's consistent inclusion in Deloitte's Technology Fast 500 list demonstrates the company's sustained growth and success in the medical technology industry.
Negative
  • None.

ENGLEWOOD, Colo., Nov. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked among all companies in the U.S. and Canada between 2019 and 2022 on Deloitte's Technology Fast 500. Zynex's revenues grew 248% over that period, with 2022 revenue reaching $158.2 million. The company estimates 2023 revenue between $189.5 and $194.5 million. The 2023 Deloitte Technology Fast 500 list can be found at www.fast500.com.

"We are honored to be included in Deloitte's Technology Fast 500 list for the fifth year in a row and ninth time overall," said Thomas Sandgaard, CEO of Zynex. "Our vision is to be the world's premier pain management provider. Continued revenue and earnings growth and recognition by organizations such as Deloitte reinforce our conviction that Zynex is on the right path toward that goal."

"As for growing companies, it's always rewarding to be recognized for the ongoing commitment it takes to navigate obstacles, transform when necessary and ultimately create a thriving business," said Christie Simons, partner, Deloitte & Touche LLP and industry leader for technology, media and telecommunications within Deloitte's Audit & Assurance practice. "Over the nearly 30 years we've been compiling the Technology Fast 500, we've seen new categories emerge, growth rates explode, and certain regional markets shine from the bright talent they attract. We are proud of all the winners for achieving this well-deserved honor."

About Deloitte's 2023 Technology Fast 500™

Now in its 29th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2019 to 2022.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $50,000, and current-year operating revenues of at least $5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About Zynex, Inc.

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

About Deloitte

Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including nearly 90% of the Fortune 500® and more than 8,500 U.S.-based private companies. At Deloitte, we strive to live our purpose of making an impact that matters by creating trust and confidence in a more equitable society. We leverage our unique blend of business acumen, command of technology, and strategic technology alliances to advise our clients across industries as they build their future. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Bringing more than 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte's approximately 457,000 people worldwide connect for impact at www.deloitte.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-named-as-a-winner-in-the-deloitte-2023-technology-fast-500-awards-for-the-5th-consecutive-year-301983266.html

SOURCE Zynex

FAQ

What is Zynex, Inc.'s ticker symbol?

The ticker symbol for Zynex, Inc. is ZYXI.

How much did Zynex's revenues grow between 2019 and 2022?

Zynex's revenues grew 248% over that period.

What is Zynex's estimated revenue for 2023?

The company estimates 2023 revenue between $189.5 and $194.5 million.

How many times has Zynex been included in Deloitte's Technology Fast 500 list?

Zynex has been included in the list for the fifth year in a row and ninth time overall.

ZYNEX INC

NASDAQ:ZYXI

ZYXI Rankings

ZYXI Latest News

ZYXI Stock Data

271.48M
15.53M
51.24%
28.05%
14.91%
Medical Distribution
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ENGLEWOOD